Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease-Reference-Cited by-同舟云学术

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease

Published:2022-11-24 Issue:2 Volume:77 Page:102-109
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

Lane Hsien‐Yuan¹²³^ORCID,Wang Shi‐Heng⁴,Lin Chieh‐Hsin²⁵⁶^ORCID

Affiliation:

1. Department of Psychiatry & Brain Disease Research Center China Medical University Hospital Taichung Taiwan

2. Graduate Institute of Biomedical Sciences China Medical University Taichung Taiwan

3. Department of Psychology, College of Medical and Health Sciences Asia University Taichung Taiwan

4. Department of Occupational Safety and Health China Medical University Taichung Taiwan

5. Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital Chang Gung University College of Medicine Kaohsiung Taiwan

6. School of Medicine Chang Gung University Taoyuan Taiwan

Funder

Chang Gung Memorial Hospital

China Medical University Hospital

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13504

Reference45 articles.

1. Effectiveness and Safety of Dementia Care Management in Primary Care

2. Cholinesterase inhibitors for Alzheimer's disease;Birks J;Cochrane Database Syst. Rev.,2006

3. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

4. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies

5. Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis;Frontiers in Psychiatry;2024-09-09

2. Physical Compatibility of Reduced Glutathione for Injection With 44 Intravenous Drugs During Simulated Y-site Administration;Clinical Therapeutics;2024-09

3. Intra-uterus phthalate exposure, ROS formation and altered mitochondrial D-loop methylation pattern at birth as potential triggers and markers of Alzheimer’s disease;Medical Hypotheses;2024-06

4. d-Amino acids: new clinical pathways for brain diseases;Trends in Molecular Medicine;2023-12

5. Elucidating the Mechanisms of Sodium Benzoate in Alzheimer Disease: Insights from Quantitative Proteomics Analysis of Serum Samples;International Journal of Neuropsychopharmacology;2023-10-24